secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEUROCRINE BIOSCIENCES INC (NBIX)
CIK:        0000914475
Form:       8-K
Filed at:   2024-10-11T23:59:59+00:00
Accession:  0000914475-24-000206
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Neurocrine appoints Kyle Gano as CEO effective Oct 11, 2024; base salary $900k
------------------------------------------------------------------------------

- Kyle Gano, Ph.D. named President and CEO effective October 11, 2024, under an amended employment agreement.
- Annual base salary of $900,000; target cash bonus of 100% of base salary.
- Promotion equity grants: $750k stock options, $300k RSUs, $450k PRSUs (total $1.5M).
- Severance includes 1.5x salary plus bonus for non-CIC termination; 2x for CIC termination with full vesting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/914475/000091447524000206/0000914475-24-000206-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/914475/000091447524000206/nbix-20241011.htm
  HTML page:      https://secwatch.observer/filing/0000914475-24-000206

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer